Thank you, Tzvika. Hello everyone. First quarter revenue was $48.1 million, within the range of our guidance. This represents a sequential increase of 3%. EMEA accounted for about 60% of revenues, North America to about 20%, Central and Latin America to about 15%, and Asia-Pacific to 5%, similar breakdown as last quarter. Direct sales accounted for about 43% of revenues, distributors increased to about 46%, and OEMs represented the remaining 11%. As you know, this quarter, we adopted FASD 123R. The aggregate impact on net income in the first quarter was $1.5 million and we expect approximately this level and higher of option-related expenses going forward. This expense actually shows up in several different line items in the P&L and we will refer you the reconciliation table attached to the press release for details. Now, for purposes of comparisons to prior periods, we will refer to non-GAAP numbers that exclude the impact of adopting this rule, amortization of intangibles and one-time items. Our gross margin was 46%, up from 45% in the fourth quarter and better than our long-term target which continued to be 45%. Total operating expenses were similar to the fourth quarter. Excluding the amortization and one-time charges, non-GAAP net loss decreased by about 30% to $2.4 million or $0.04 per share in the first quarter, which was within the range of our guidance. This is an improvement from a non-GAAP loss of $3.8 million or $0.06 per basic share in the fourth quarter. Turning to the balance sheet, cash and cash equivalents were $109 million at the end of the first quarter. We continue our operations expectedness and our inventory was down again this quarter, this time by about $5 million, and our DSO was stable at 76 days. As we Tzvika mentioned, during the second quarter, we’ve noted that the level of new orders from the cellular mobile unit will come even lower than we’ve previously anticipated. This event has triggered goodwill and other intangible impairment analysis. We started this analysis and reported that it usually takes few weeks. As of our most recent annual impairment test, the intangible assets attributable to the CMU were around $30 million, but at this point we cannot advise reasonable estimate of such potential impairments if any. In the second quarter, we expect revenue in the range of $48 million to $52 million. Based on this revenue level, we expect non-GAAP net loss per shares, which excludes amortization, the effect of the stock option expensing, and possible charge for the CMU business to range between $0.02 and $0.05. Now, we would be pleased to take your questions.